These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 38755145)
1. TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression. Garcia-Montojo M; Fathi S; Rastegar C; Simula ER; Doucet-O'Hare T; Cheng YHH; Abrams RPM; Pasternack N; Malik N; Bachani M; Disanza B; Maric D; Lee MH; Wang H; Santamaria U; Li W; Sampson K; Lorenzo JR; Sanchez IE; Mezghrani A; Li Y; Sechi LA; Pineda S; Heiman M; Kellis M; Steiner J; Nath A Nat Commun; 2024 May; 15(1):4163. PubMed ID: 38755145 [TBL] [Abstract][Full Text] [Related]
2. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Janssens J; Van Broeckhoven C Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071 [TBL] [Abstract][Full Text] [Related]
3. Endogenous retroviruses and TDP-43 proteinopathy form a sustaining feedback driving intercellular spread of Drosophila neurodegeneration. Chang YH; Dubnau J Nat Commun; 2023 Feb; 14(1):966. PubMed ID: 36810738 [TBL] [Abstract][Full Text] [Related]
4. PABPN1 suppresses TDP-43 toxicity in ALS disease models. Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692 [TBL] [Abstract][Full Text] [Related]
5. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy. Ihara R; Matsukawa K; Nagata Y; Kunugi H; Tsuji S; Chihara T; Kuranaga E; Miura M; Wakabayashi T; Hashimoto T; Iwatsubo T Hum Mol Genet; 2013 Nov; 22(22):4474-84. PubMed ID: 23804749 [TBL] [Abstract][Full Text] [Related]
6. Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Nolan M; Scott C; Gamarallage MP; Lunn D; Carpenter K; McDonough E; Meyer D; Kaanumalle S; Santamaria-Pang A; Turner MR; Talbot K; Ansorge O Acta Neuropathol Commun; 2020 Jul; 8(1):98. PubMed ID: 32616036 [TBL] [Abstract][Full Text] [Related]
8. Mislocalization of Nup62 Contributes to TDP-43 Proteinopathy in ALS/FTLD. Nag N; Tripathi T ACS Chem Neurosci; 2022 Sep; 13(17):2544-2546. PubMed ID: 36001801 [TBL] [Abstract][Full Text] [Related]
9. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Liu YC; Chiang PM; Tsai KJ Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586 [TBL] [Abstract][Full Text] [Related]
10. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. Wang P; Deng J; Dong J; Liu J; Bigio EH; Mesulam M; Wang T; Sun L; Wang L; Lee AY; McGee WA; Chen X; Fushimi K; Zhu L; Wu JY PLoS Genet; 2019 May; 15(5):e1007947. PubMed ID: 31100073 [TBL] [Abstract][Full Text] [Related]
12. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Gao J; Wang L; Yan T; Perry G; Wang X Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085 [TBL] [Abstract][Full Text] [Related]
13. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD. Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517 [TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of human endogenous retrovirus-K transcripts in postmortem premotor cortex fails to confirm elevated expression of HERV-K RNA in amyotrophic lateral sclerosis. Garson JA; Usher L; Al-Chalabi A; Huggett J; Day EF; McCormick AL Acta Neuropathol Commun; 2019 Mar; 7(1):45. PubMed ID: 30885274 [TBL] [Abstract][Full Text] [Related]
15. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Hunter M; Spiller KJ; Dominique MA; Xu H; Hunter FW; Fang TC; Canter RG; Roberts CJ; Ransohoff RM; Trojanowski JQ; Lee VM Acta Neuropathol Commun; 2021 Aug; 9(1):140. PubMed ID: 34412701 [TBL] [Abstract][Full Text] [Related]
16. RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy. Chen HJ; Topp SD; Hui HS; Zacco E; Katarya M; McLoughlin C; King A; Smith BN; Troakes C; Pastore A; Shaw CE Brain; 2019 Dec; 142(12):3753-3770. PubMed ID: 31605140 [TBL] [Abstract][Full Text] [Related]
17. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy. Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147 [TBL] [Abstract][Full Text] [Related]
18. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Scotter EL; Chen HJ; Shaw CE Neurotherapeutics; 2015 Apr; 12(2):352-63. PubMed ID: 25652699 [TBL] [Abstract][Full Text] [Related]
19. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771 [TBL] [Abstract][Full Text] [Related]
20. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Smethurst P; Risse E; Tyzack GE; Mitchell JS; Taha DM; Chen YR; Newcombe J; Collinge J; Sidle K; Patani R Brain; 2020 Feb; 143(2):430-440. PubMed ID: 32040555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]